UNIVERSITY OF UTAH
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1850-02-28
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.utah.edu
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System
Early Phase 1
Recruiting
- Conditions
- Breast Cancer
- Interventions
- Device: Muse MRgFUS System
- First Posted Date
- 2022-03-22
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 34
- Registration Number
- NCT05291507
- Locations
- 🇺🇸
Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah, United States
Feasibility of Virtual Reality Delivery of Pain Neuroscience Education
Not Applicable
Completed
- Conditions
- Low Back Pain
- Interventions
- Behavioral: Usual Care Physical TherapyBehavioral: VR Pain Education
- First Posted Date
- 2022-03-17
- Last Posted Date
- 2023-02-02
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 52
- Registration Number
- NCT05285462
- Locations
- 🇺🇸
Belmont University, Nashville, Tennessee, United States
Exploring the Role of Neuroactive Steroids in Tourette Syndrome
Not Applicable
- Conditions
- Tourette Syndrome in Children
- Interventions
- Behavioral: Tic suppression task
- First Posted Date
- 2022-03-16
- Last Posted Date
- 2022-03-16
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 120
- Registration Number
- NCT05281445
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
Simulation Training for Labor and Delivery Providers to Address HIV Stigma During Childbirth in Tanzania
Not Applicable
Completed
- Conditions
- Pregnancy RelatedHivStigmatization
- Interventions
- Behavioral: MAMA Intervention
- First Posted Date
- 2022-03-09
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 503
- Registration Number
- NCT05271903
- Locations
- 🇹🇿
Kilimanjaro Christian Medical Centre, Moshi, Tanzania
Prospective Evaluation Analysis and Kinetics Registry
- First Posted Date
- 2022-02-18
- Last Posted Date
- 2023-09-26
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 167
- Registration Number
- NCT05247320
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
Phase 2
Recruiting
- Conditions
- Congenital Diaphragmatic HerniaPulmonary Hypertension
- Interventions
- Other: Placebo
- First Posted Date
- 2022-01-21
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 40
- Registration Number
- NCT05201144
- Locations
- 🇺🇸
Primary Children's Hospital, Salt Lake City, Utah, United States
One MORE for Chronic Pain
Not Applicable
Completed
- Conditions
- Chronic Pain
- Interventions
- Behavioral: One MORE
- First Posted Date
- 2022-01-18
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 40
- Registration Number
- NCT05194241
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial
Phase 2
Recruiting
- Conditions
- Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
- Interventions
- Biological: Pneumococcal Polyvalent VaccineOther: Questionnaire Administration
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 60
- Registration Number
- NCT05183854
- Locations
- 🇺🇸
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Phase 2
Recruiting
- Conditions
- Stage IVA Prostate Cancer AJCC v8Stage IVB Prostate Cancer AJCC v8Stage IV Prostate Cancer AJCC v8Castration-Resistant Prostate CarcinomaMetastatic Prostate Adenocarcinoma
- Interventions
- First Posted Date
- 2021-12-23
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 33
- Registration Number
- NCT05168618
- Locations
- 🇺🇸
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
Timely Intravenous Magnesium for Asthma in Children
Phase 2
Completed
- Conditions
- Asthma
- Interventions
- Drug: Magnesium Sulfate, HeptahydrateDrug: 0.9% saline
- First Posted Date
- 2021-12-22
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 52
- Registration Number
- NCT05166811
- Locations
- 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States
🇺🇸Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Primary Children's Hospital, Salt Lake City, Utah, United States
© Copyright 2025. All Rights Reserved by MedPath